4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-024225
President and CEO bought 8,680 shares at $5.81 ($50,433)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2019-09-23 | Purchase | +8,680 | $5.81 | $50,433 | 623,506 | D |
| Open-market purchases · 8,680 sh · avg $5.81 · $50,433 | |||||||
Loading xslF345X03/doc4.xml…